Drug Topics
CONTINUE TO SITE >

OR WAIT 15 SECS

This Week on Drug Topics: February 8 to 12

February 8, 2021

Here’s a preview of the featured content to watch for this week on Drug Topics®.

Coronavirus Research News

With an estimated 42.4 million coronavirus disease 2019 (COVID-19) vaccine doses distributed as of this article’s press time and more than 59 million doses delivered in the United States, keeping up with pandemic news is more important than ever. Check back to Drug Topics® to stay informed on the latest coronavirus-related news and research.

Read more coronavirus-related news.

American Heart Month

February is American Heart Month. Check out our Heart Health section for the latest news and research on cardiovascular-related issues, including COVID-19 effects on heart disease risk.

Read more on heart health.

Medical World News Updates

In part 2 of the interview, Sara Revolinski, PharmD, BCPS, professor Karen Mackinnon, BPharm, RPh, and second-year pharmacy student Celena Ho from the Medical School of Wisconsin Pharmacy School discuss a new program that is training pharmacy students to administer COVID-19 vaccines.

Watch part 1 of the interview.

Drug Topics® interviewed Kaitlyn Rivard, PharmD, infectious diseases clinical pharmacist at the Cleveland Clinic, on her role in getting their COVID-19 vaccination program off the ground. Rivard discusses key insights, advice, and experience in developing an effective COVID-19 vaccination program.

Watch more expert interviews.

Drug Topics® Journal, February 2021 Digital Edition

The February 2021 digital edition of Drug Topics Journal is now available on DrugTopics.com. In this issue, pharmacists share tips for engaging with patients online, and our cover story highlights practicing culturally competent care to fight health disparities.

View the February digital issue.

In Case You Missed It: Johnson & Johnson Submits EUA for COVID-19 Vaccine Candidate

Johnson & Johnson has submitted an emergency use authorization (EUA) to the FDA for its single-dose vaccine candidate for COVID-19.

Read more